Report Detail

Medical Devices & Consumables Global CRM197 Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4617176
  • |
  • 26 September, 2024
  • |
  • Global
  • |
  • 90 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

CRM197 is a non-toxic mutant of diphtheria toxin and it"s widely used as a carrier protein for conjugate vaccines.
According to our (Global Info Research) latest study, the global CRM197 market size was valued at US$ 182 million in 2023 and is forecast to a readjusted size of USD 258 million by 2030 with a CAGR of 5.1% during review period.
Pfizer Inc is one of the most important global manufacturers of CRM197, holds a share of over 85%. North America is the largest market, occupied for over 75%. In terms of type, research grade is the largest segment, with a share of over 85%. And in terms of application, pneumococcal conjugate vaccine segment holds a share of about 90%.
This report is a detailed and comprehensive analysis for global CRM197 market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global CRM197 market size and forecasts, in consumption value ($ Million), 2019-2030
Global CRM197 market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global CRM197 market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global CRM197 market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRM197
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CRM197 market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Ligand Pharmaceuticals, CanSino Biologic, Beijing Kexing Biology Product, Scarab Genomics, Xpress Biologics, Fina Biosolutions, Eubiologics, EirGenix Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
CRM197 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
CRM197 market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Research Grade CRM197
cGMP Grade CRM197
Market segment by Application
Pneumococcal Conjugate Vaccine
Meningococcal Polysaccharide Conjugate Vaccine
Others
Market segment by players, this report covers
Pfizer Inc.
Ligand Pharmaceuticals
CanSino Biologic
Beijing Kexing Biology Product
Scarab Genomics
Xpress Biologics
Fina Biosolutions
Eubiologics
EirGenix Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRM197 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRM197, with revenue, gross margin, and global market share of CRM197 from 2019 to 2024.
Chapter 3, the CRM197 competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CRM197 market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRM197.
Chapter 13, to describe CRM197 research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of CRM197 by Type
    • 1.3.1 Overview: Global CRM197 Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global CRM197 Consumption Value Market Share by Type in 2023
    • 1.3.3 Research Grade CRM197
    • 1.3.4 cGMP Grade CRM197
  • 1.4 Global CRM197 Market by Application
    • 1.4.1 Overview: Global CRM197 Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pneumococcal Conjugate Vaccine
    • 1.4.3 Meningococcal Polysaccharide Conjugate Vaccine
    • 1.4.4 Others
  • 1.5 Global CRM197 Market Size & Forecast
  • 1.6 Global CRM197 Market Size and Forecast by Region
    • 1.6.1 Global CRM197 Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global CRM197 Market Size by Region, (2019-2030)
    • 1.6.3 North America CRM197 Market Size and Prospect (2019-2030)
    • 1.6.4 Europe CRM197 Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific CRM197 Market Size and Prospect (2019-2030)
    • 1.6.6 South America CRM197 Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa CRM197 Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Pfizer Inc.
    • 2.1.1 Pfizer Inc. Details
    • 2.1.2 Pfizer Inc. Major Business
    • 2.1.3 Pfizer Inc. CRM197 Product and Solutions
    • 2.1.4 Pfizer Inc. CRM197 Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Pfizer Inc. Recent Developments and Future Plans
  • 2.2 Ligand Pharmaceuticals
    • 2.2.1 Ligand Pharmaceuticals Details
    • 2.2.2 Ligand Pharmaceuticals Major Business
    • 2.2.3 Ligand Pharmaceuticals CRM197 Product and Solutions
    • 2.2.4 Ligand Pharmaceuticals CRM197 Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Ligand Pharmaceuticals Recent Developments and Future Plans
  • 2.3 CanSino Biologic
    • 2.3.1 CanSino Biologic Details
    • 2.3.2 CanSino Biologic Major Business
    • 2.3.3 CanSino Biologic CRM197 Product and Solutions
    • 2.3.4 CanSino Biologic CRM197 Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 CanSino Biologic Recent Developments and Future Plans
  • 2.4 Beijing Kexing Biology Product
    • 2.4.1 Beijing Kexing Biology Product Details
    • 2.4.2 Beijing Kexing Biology Product Major Business
    • 2.4.3 Beijing Kexing Biology Product CRM197 Product and Solutions
    • 2.4.4 Beijing Kexing Biology Product CRM197 Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Beijing Kexing Biology Product Recent Developments and Future Plans
  • 2.5 Scarab Genomics
    • 2.5.1 Scarab Genomics Details
    • 2.5.2 Scarab Genomics Major Business
    • 2.5.3 Scarab Genomics CRM197 Product and Solutions
    • 2.5.4 Scarab Genomics CRM197 Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Scarab Genomics Recent Developments and Future Plans
  • 2.6 Xpress Biologics
    • 2.6.1 Xpress Biologics Details
    • 2.6.2 Xpress Biologics Major Business
    • 2.6.3 Xpress Biologics CRM197 Product and Solutions
    • 2.6.4 Xpress Biologics CRM197 Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Xpress Biologics Recent Developments and Future Plans
  • 2.7 Fina Biosolutions
    • 2.7.1 Fina Biosolutions Details
    • 2.7.2 Fina Biosolutions Major Business
    • 2.7.3 Fina Biosolutions CRM197 Product and Solutions
    • 2.7.4 Fina Biosolutions CRM197 Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Fina Biosolutions Recent Developments and Future Plans
  • 2.8 Eubiologics
    • 2.8.1 Eubiologics Details
    • 2.8.2 Eubiologics Major Business
    • 2.8.3 Eubiologics CRM197 Product and Solutions
    • 2.8.4 Eubiologics CRM197 Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Eubiologics Recent Developments and Future Plans
  • 2.9 EirGenix Inc.
    • 2.9.1 EirGenix Inc. Details
    • 2.9.2 EirGenix Inc. Major Business
    • 2.9.3 EirGenix Inc. CRM197 Product and Solutions
    • 2.9.4 EirGenix Inc. CRM197 Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 EirGenix Inc. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global CRM197 Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of CRM197 by Company Revenue
    • 3.2.2 Top 3 CRM197 Players Market Share in 2023
    • 3.2.3 Top 6 CRM197 Players Market Share in 2023
  • 3.3 CRM197 Market: Overall Company Footprint Analysis
    • 3.3.1 CRM197 Market: Region Footprint
    • 3.3.2 CRM197 Market: Company Product Type Footprint
    • 3.3.3 CRM197 Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global CRM197 Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global CRM197 Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global CRM197 Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global CRM197 Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America CRM197 Consumption Value by Type (2019-2030)
  • 6.2 North America CRM197 Market Size by Application (2019-2030)
  • 6.3 North America CRM197 Market Size by Country
    • 6.3.1 North America CRM197 Consumption Value by Country (2019-2030)
    • 6.3.2 United States CRM197 Market Size and Forecast (2019-2030)
    • 6.3.3 Canada CRM197 Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico CRM197 Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe CRM197 Consumption Value by Type (2019-2030)
  • 7.2 Europe CRM197 Consumption Value by Application (2019-2030)
  • 7.3 Europe CRM197 Market Size by Country
    • 7.3.1 Europe CRM197 Consumption Value by Country (2019-2030)
    • 7.3.2 Germany CRM197 Market Size and Forecast (2019-2030)
    • 7.3.3 France CRM197 Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom CRM197 Market Size and Forecast (2019-2030)
    • 7.3.5 Russia CRM197 Market Size and Forecast (2019-2030)
    • 7.3.6 Italy CRM197 Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific CRM197 Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific CRM197 Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific CRM197 Market Size by Region
    • 8.3.1 Asia-Pacific CRM197 Consumption Value by Region (2019-2030)
    • 8.3.2 China CRM197 Market Size and Forecast (2019-2030)
    • 8.3.3 Japan CRM197 Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea CRM197 Market Size and Forecast (2019-2030)
    • 8.3.5 India CRM197 Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia CRM197 Market Size and Forecast (2019-2030)
    • 8.3.7 Australia CRM197 Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America CRM197 Consumption Value by Type (2019-2030)
  • 9.2 South America CRM197 Consumption Value by Application (2019-2030)
  • 9.3 South America CRM197 Market Size by Country
    • 9.3.1 South America CRM197 Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil CRM197 Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina CRM197 Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa CRM197 Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa CRM197 Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa CRM197 Market Size by Country
    • 10.3.1 Middle East & Africa CRM197 Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey CRM197 Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia CRM197 Market Size and Forecast (2019-2030)
    • 10.3.4 UAE CRM197 Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 CRM197 Market Drivers
  • 11.2 CRM197 Market Restraints
  • 11.3 CRM197 Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 CRM197 Industry Chain
  • 12.2 CRM197 Upstream Analysis
  • 12.3 CRM197 Midstream Analysis
  • 12.4 CRM197 Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on CRM197. Industry analysis & Market Report on CRM197 is a syndicated market report, published as Global CRM197 Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of CRM197 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,599.56
    3,899.34
    5,199.12
    3,118.08
    4,677.12
    6,236.16
    496,944.00
    745,416.00
    993,888.00
    291,310.80
    436,966.20
    582,621.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report